Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Acquires UK Diagnostics Distributor for $1.9M

NEW YORK (GenomeWeb News) – Cepheid today said that it will acquire Stretton Scientific, a UK-based distributor of diagnostic and monitoring equipment, for around £1.2 million ($1.9 million).
Privately held Stretton already distributes Cepheid’s SmartCycler system to customers, including the National Health Service, throughout the UK. The acquisition is expected to “augment our newly established UK-based direct sales team,” Cepheid CEO John Bishop said in a statement.
Cepheid said that it will pay the $1.9 million acquisition price in cash. It expects to close the transaction early this month, subject to customary closing conditions. Cepheid noted that the deal is not expected to have a material impact on its fourth-quarter financial results.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.